Survey of the suitability of breast-cancer patients for inclusion into adjuvant clinical trials over 11 consecutive weeks in a single new-patient clinic.
Canney
P A
PA
McIlroy
P
P
D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D006113:United Kingdom
D004317:Doxorubicin; D003520:Cyclophosphamide